Sinn, Bruno V. http://orcid.org/0000-0002-1257-9799
Fu, Chunxiao
Lau, Rosanna
Litton, Jennifer
Tsai, Tsung-Heng
Murthy, Rashmi
Tam, Alda
Andreopoulou, Eleni
Gong, Yun
Murthy, Ravi
Gould, Rebekah
Zhang, Ya
King, Tari A.
Viale, Agnes
Andrade, Victor
Giri, Dilip
Salgado, Roberto
Laios, Ioanna
Sotiriou, Christos
Marginean, Esmeralda C.
Kwiatkowski, Danielle N.
Layman, Rachel M.
Booser, Daniel
Hatzis, Christos
Vicente Valero, V.
Fraser Symmans, W.
Article History
Received: 5 January 2019
Accepted: 30 April 2019
First Online: 30 May 2019
Competing interests
: W.F.S., B.V.S., C.H., C.F. and R.L. are co-inventors on patent WO2017189976A1 “Targeted measure of transcriptional activity related to hormone receptors”. W.F.S., C.F. and R.L. own shares of Delphi Diagnostics, without employment or administrative position. W.F.S. owns shares of IONIS Pharmaceuticals and has received honoraria from Merck and from Almac Diagnostics during the past 12 months. J.L. received grants or research support from Pfizer, Astra Zeneca, Genentech, EMD-Serono and GSK, is member of the speaker’s bureau at Medlearning group and PER and advisory committee member (uncompensated) at Pfizer and Astra-Zeneca. A.T. received research grants from Guerbet LCC and consulted Merit Medical, Jounce Therapeutics, AbbVie. R.S. participated in an advisory board at BMS, received travel grants and research support from Merck, Roche. T.A.K. served as speaker for Genomic Health. C.H. is currently an employee of Bristol-Myers Squibb. The other authors declare no competing interests.